Searle, Kaken Pharmaceutical Co. Ltd. deal

Kaken will receive exclusive rights in Japan to Searle's Arthrotec, a non-steroidal anti-inflammatory compound that includes gastrointestinal mucosal protection against ulcers. Arthrotec was approved...